Dramatically Increased Titer
Enhanced flux and pathway blockade lead to significantly higher Citric Acid accumulation in the fermentation broth.
Citric Acid is the most widely produced organic acid globally, used extensively as an acidulant, flavor enhancer, and preservative in food, as well as a chelating agent in chemical and pharmaceutical industries. Production relies almost entirely on the fermentation of Aspergillus niger . However, industrial strains often suffer from a low acid production rate in Aspergillus niger fermentation due to tight metabolic control and low yield. Furthermore, the traditional calcium citrate precipitation method leads to high extraction cost and substantial gypsum waste. This necessitates a solution that boosts both productivity and efficient product recovery.
CD Biosynsis offers a synthetic biology service focused on maximizing Citric Acid yield and simplifying downstream processing. Our core strategy involves modification of Aspergillus niger metabolic pathway , focusing on boosting flux through glycolysis and the initial stages of the TCA cycle, while knocking out enzymes that consume Citrate (e.g., isocitrate dehydrogenase) to ensure maximum accumulation. This is coupled with the optimization of cell membrane permeability by modifying membrane composition or overexpressing specific Citrate transporters. Enhanced permeability allows the Citric Acid to be efficiently secreted into the medium, leading to higher titers, reduced intracellular toxicity, and simplified downstream processing. This integrated approach aims to deliver a high-yield, pure, and economically viable Citric Acid product.
Get a QuoteMaximizing the efficiency of Citric Acid bioproduction faces these key challenges:
An effective solution must boost the upstream supply, block the downstream consumption, and facilitate efficient product export.
CD Biosynsis utilizes advanced metabolic engineering to optimize Citric Acid production in Aspergillus niger:
Modification of Aspergillus niger Metabolic Pathway
We overexpress key upstream enzymes (e.g., PFK) and knock out enzymes consuming Citrate (IDH) to redirect maximum carbon flux toward Citrate accumulation.
Optimization of Cell Membrane Permeability
We screen for or engineer Citrate-specific transporters/exporters to boost product secretion, relieving intracellular feedback inhibition and toxicity.
Pyruvate Carboxylase (PC) Optimization
We increase the activity or expression of PC to ensure a constant supply of Oxaloacetate (OAA) , the key co-substrate for the final Citrate synthesis step.
Morphology and Stress Tolerance Engineering
We modify the fungal morphology to favor a pellet form over a mycelial form to improve mass transfer, viscosity control, and tolerance to high Citric Acid concentrations.
This systematic approach is focused on optimizing every stage from carbon uptake to final product secretion to maximize economic efficiency.
Our Citric Acid engineering service is dedicated to pursuing the following production goals:
Dramatically Increased Titer
Enhanced flux and pathway blockade lead to significantly higher Citric Acid accumulation in the fermentation broth.
Reduced Downstream Processing Cost
High purity and concentration, combined with optimized secretion, simplify initial recovery , bypassing costly precipitation steps.
Minimized Byproduct Formation
Metabolic engineering reduces the co-production of isocitrate and other unwanted organic acids, simplifying purification. [Image of Cost Reduction Icon]
Low Environmental Burden
Efficient non-precipitation recovery methods and optimized fermentation reduce gypsum waste and energy consumption .
Robust Fungal Platform
A. niger is a well-established, safe (GRAS) organism with a proven track record in industrial acid production.
We provide a biosynthetic platform aimed at maximizing the yield and minimizing the purification and environmental costs of Citric Acid production.
Our Citric Acid strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product integrity.
Explore the potential for a high-performance, sustainable Citric Acid supply. CD Biosynsis provides customized strain engineering solutions:
Why is Aspergillus niger the standard host?
A. niger is capable of converting cheap, simple sugars into large amounts of Citric Acid and is a GRAS organism with a history of industrial use spanning over $100$ years, making it the most economical choice.
What is the role of IDH (Isocitrate Dehydrogenase) in this process?
IDH converts Isocitrate (which is formed from Citrate) into $\alpha\text{-Ketoglutarate, thus consuming the product. Knocking out IDH effectively acts as a metabolic dam, forcing Citrate to accumulate.
How does membrane permeability affect the yield?
Citric Acid accumulation inside the cell causes acidification and toxicity. By increasing the rate of export , the cell can tolerate higher production rates, preventing feedback inhibition and allowing for higher final titers.
What is the primary byproduct issue?
The primary byproduct is Isocitric Acid, which is an isomer of Citric Acid. High levels of Isocitrate contamination reduce product quality and complicate crystallization . Our process minimizes this through targeted gene modification.
What is the estimated project timeline?
A project involving multi-gene pathway modification, transporter screening, and fermentation optimization in a fungal host typically requires 18-22 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.